Oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants

Pediatrics and Neonatology

Volumn 53, Issue 6, 2012, Pages 346-353

  Lee, Cheng Han ^a,b   Chen, Hsiao Neng ^a,b   Tsao, Long Yen ^a,b   Hsiao, Chien Chou ^a,b   Lee, Meng Luen ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

indomethacin; oral ibuprofen; patent ductus arteriosus; very low birth weight infants

Indexed keywords

CREATININE; IBUPROFEN; INDOMETACIN;

ARTICLE; BODY WEIGHT; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; OLIGURIA; PATENT DUCTUS ARTERIOSUS; RETROSPECTIVE STUDY; SIDE EFFECT; TAIWAN; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; URINE VOLUME; VERY LOW BIRTH WEIGHT;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; DUCTUS ARTERIOSUS, PATENT; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; RETROSPECTIVE STUDIES;

EID: 84871922085     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2012.08.011     Document Type: Article

References (34)

1. J.A. Lemons, C.R. Bauer, and W. Oh Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network Pediatrics 107 2001 E1
2. F.J. Weir, A. Ohlsson, T.L. Myhr, K. Fong, and M.L. Ryan A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity Eur J Pediatr 158 1999 484 487
3. W.M. Gersony, G.J. Peckham, R.C. Ellison, O.S. Miettinen, and A.S. Nadas Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study J Pediatr 102 1983 895 906
4. E.R. Hermes-DeSantis, and R.I. Clyman Patent ductus arteriosus: pathophysiology and management J Perinatol 26 2006 14 18
5. B. Van Overmeire, and S. Chemtob The pharmacologic closure of the patent ductus arteriosus Semin Fetal Neonatal Med 10 2005 177 184
6. B. Van Overmeire, K. Smets, and D. Lecoutere A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus N Engl J Med 343 2000 674 681
7. F. Van Bel, G.L. Guit, J. Schipper, M. Van de Bor, and J. Baan Indomethacin induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging J Pediatr 118 1991 621 626
8. R. Mardoum, R. Bejar, T.A. Merritt, and C. Berry Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants J Pediatr 118 1991 112 115
9. R.C. Coombs, M.E. Morgan, G.M. Durbin, I.W. Booth, and A.S. McNeish Gut blood flow velocities in newborn: effects of patent ductus arteriosus and parenteral indomethacin Arch Dis Child 65 1990 1067 1071
10. A. Varvarigou, C.L. Bardin, K. Beharry, S. Chemtob, A. Papageorgiou, and J.V. Aranda Early ibuprofen administration to prevent patent ductus arteriosus in premature infants JAMA 275 1996 539 544
11. F. Mosca, M. Bray, M. Lattanzio, M. Fumagalli, and C. Tosetto Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus J Pediatr 131 1997 549 554
12. P. Lago, T. Bettiol, and S. Salvadori Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial Eur J Pediatr 161 2002 202 207
13. G. Poon Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus Proc (Bayl Univ Med Cent) 20 2007 83 85
14. P. Hariprasad, V. Sundarrajan, G. Srimathy, B. Suthagar, and B.S. Ramadevi Oral ibuprofen for closure of hemodinamically significant PDA in premature neonates Indian Pediatr 39 2002 99 100
15. A. Cherif, N. Khrouf, and S. Jabnoun Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus Pediatrics 122 2008 1256 1261
16. O. Erdeve, T. Gokmen, N. Altug, and U. Dilmen Oral versus intravenous ibuprofen: which is better in closure of patent ductus arteriosus? Pediatrics 123 2009 763
17. A. Cherif, S. Jabnoun, and N. Khrouf Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants Am J Perinatol 24 2007 339 345
18. H. Aly, W. Lotfy, N. Badrawi, M. Ghawas, I.E. Abdel-Meguid, and T.A. Hammad Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study Am J Perinatol 24 2007 267 270
19. S.H. Fakhraee, Z. Badiee, S. Mojtahedzadeh, M. Kazemian, and R. Kelishadi Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants Zhongguo Dang Dai Er Ke Za Zhi 9 2007 399 403
20. U. Chotigeat, K. Jirapapa, and T. Layangkool A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants J Med Assoc Thai 86 2003 563 569
21. S. Supapannachart, A. Limrungsikul, and P. Khowsathit Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomised trial at Ramathibodi Hospital J Med Assoc Thai 85 2002 1252 1258
22. T. Gokmen, O. Erdeve, N. Altug, S.S. Oguz, N. Uras, and U. Dilmen Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus J Pediatr 158 2011 549-554.e1
23. L.J. Jones, P. Craven, J. Attia, A. Thakkinstian, and I. Wright Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants Arch Dis Child Fetal Neonatal Ed 96 2011 F45 F52
24. J.V. Aranda, and R. Thomas Systematic review: ibuprofen in preterm newborns Semin Perinatol 30 2006 114 120
25. A. Gimeno Navarro, V. Modesto Alapont, F. Morcillo Sopena, C. Fernández Gilino, I. Izquierdo Macián, and A. Gutiérrez Laso Ibuprofen versus indomethacin in the preterm persistent patent ductus arteriosus therapy: review and meta-analysis An Pediatr (Barc) 67 2007 309 318
26. A. Ohlsson, R. Walia, and S.S. Shah Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants Cochrane Database Syst Rev 14 4 2010 CD003481
27. E. Heyman, I. Morag, D. Batash, R. Keidar, S. Baram, and M. Berkovitch Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study Pediatrics 112 2003 e354
28. V. Sangtawesin, C. Sangtawesin, and C. Raksasinborisut Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity J Med Assoc Thai 89 2006 314 321
29. A. Cherif, N. Khrouf, and S. Jabnoun Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus Pediatrics 122 2008 e1256 e1261
30. H. Niinikoski, M. Alanen, T. Parvinen, R. Aantaa, H. Ekblad, and P. Kero Surgical closure of patent ductus arteriosus in very-low-birth-weight infants Pediatr Surg Int 17 2001 338 341
31. V.L. Vida, P. Lago, and S. Salvatori Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants? Ann Thorac Surg 87 2009 1509 1515
32. F. Tiker, and S.V. Yildirim Acute renal impairment after oral ibuprofen for medical Closure of patent ductus arteriosus Indian Pediatr 44 2007 54 55
33. Soo Jin Lee, Ji Young Kim, Eun Ae Park, and Sejung Sohn The pharmacological treatment of patent ductus arteriosus in premature infants with respiratory distress syndrome: oral ibuprofen vs. indomethacin Korean J Pediatr 51 9 2008 956 963
34. J.B. Gouyon, and Y. Kibleur Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants Clin Ther 32 10 2010 1740 1748